{"pub_date": "2016-06-03T00:00:00Z", "subsection_name": "DealBook", "lead_paragraph": "The health care giant is criticized by many investors for its mediocre shareholder returns and its lack of merger-and-acquisition activity.", "print_page": null, "document_type": "article", "byline": {"person": [{"rank": 1, "organization": "", "lastname": "CYRAN", "firstname": "Robert", "role": "reported"}], "original": "By ROBERT CYRAN"}, "multimedia": [], "section_name": "Business Day", "headline": {"content_kicker": "Breakingviews", "main": "Johnson &amp; Johnson Is Urged to Slim Down", "kicker": "Breakingviews"}, "source": "The New York Times", "blog": [], "word_count": "388", "web_url": "http://www.nytimes.com/2016/06/03/business/dealbook/johnson-johnson-is-urged-to-slim-down.html", "slideshow_credits": null, "news_desk": "Business", "type_of_material": "News", "snippet": "The health care giant is criticized by many investors for its mediocre shareholder returns and its lack of merger-and-acquisition activity.", "_id": "57509af838f0d86ce33330ac", "abstract": null, "keywords": [{"rank": "1", "name": "organizations", "value": "Eli Lilly and Company", "is_major": "N"}, {"rank": "2", "name": "organizations", "value": "Johnson & Johnson", "is_major": "N"}, {"rank": "3", "name": "organizations", "value": "Abbott Laboratories", "is_major": "N"}, {"rank": "4", "name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "N"}, {"rank": "5", "name": "subject", "value": "Medical Devices", "is_major": "N"}]}